Pharmacogenomics is a big term that describes what is a giant leap forward in medicine: using a person’s genetic makeup in prescribing drug treatments that are most likely to be successful.
“We all have variants in some genes that will alter drug response,” says Dr. Richard Weinshilboum, director of the Pharmacogenomics Program at Mayo Clinic’s Center for Individualized Medicine. “Having that kind of information pre-emptively in the electronic health record will bring a day when we will change the way in which we treat everybody, because we will be doing it on an individualized basis, automatically."
Dr. Weinshilboum is among the experts discussing the future of pharmacogenomics at this week's Individualizing Medicine Conference 2016 at the Mayo Civic Center in Rochester, Minnesota.
In this Mayo Clinic Minute, Dr. Weinshilboum explains the concept of pharmacogenomics and how it will change the way doctors prescribe certain drug therapies. Jeff Olsen reports.
Journalists: Broadcast-quality video pkg (0:58) is in the downloads. Read the script.
About the Individualizing Medicine Conference: Making pharmacogenomics more readily available to patients is a topic of discussion at the conference. Experts are presenting ways to apply individualized medicine to a variety of conditions. Journalists are invited to interview these experts on-site or cover their presentations via webcast or Facebook Live for a variety of health and medical stories.